Francisco Novillo

Francisco Novillo

Auto-generated profile, based on publicly available information

Francisco Novillo

Faculty of Medicine, Pontificia Universidad Católica de Chile

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
GRGabriel Rada
Gabriel Rada
CACamila Avila-Oliver
Camila Avila-Oliver
JRJosé Ramos-Rojas
José Ramos-Rojas
JVJuan Vasquez-Laval
Juan Vasquez-Laval
CVCamilo Vergara
Camilo Vergara
DBDiana Biscay
Diana Biscay
Randomized controlled trials (RCTs) are the cornerstone of evidence-based healthcare, providing the most reliable means of assessing the efficacy and safety of health interventions. However, their rapidly growing volume and dispersion across diverse sources, such as bibliographic databases, preprint servers, and trial registries, pose major challenges for evidence synthesis, clinical guideline development, and health technology assessment. Despite longstanding recognition of their importance and multiple initiatives to improve accessibility, there is still no comprehensive, freely available, and continuously updated resource of trial records. To address this gap, the Epistemonikos Foundation developed the Epistemonikos Database of Trials (ED-Trials), a continuously updated repository of RCTs identified from more than 30 sources, including bibliographic databases, preprint servers, international trial registries, and other search sources. This paper describes the methods used to identify and classify trial records, outlines the key features of the search interface, and reports the database status as of October 2025. ED-Trials now includes more than 1.5 million unique trial records, many of which are not indexed in MEDLINE or other conventional bibliographic databases. It represents a significant scholarly and technical achievement, offering a freely accessible and user-friendly resource that enables more efficient, comprehensive, and up-to-date identification of randomized controlled trials, thereby strengthening the foundation of evidence-based healthcare.

24 April 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
MOMatt Oxman
Matt Oxman
LCLeila Cusack
Leila Cusack
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
CÁCamila Ávila
Camila Ávila
JPJaviera Peña
Javiera Peña
LNLena Nordheim
Lena Nordheim
Objectives To make informed health choices, and avoid waste and unnecessary suffering, people need critical thinking skills. However, like health interventions, educational interventions can have adverse effects. In this systematic review, the objective was to assess the extent to which researchers have included potential adverse effects in studies of interventions intended to improve the critical thinking of laypeople about health choices. Design This study was a systematic review, in which we updated the search for an earlier systematic review of intended effects of relevant interventions. The earlier review did not address potential adverse effects. We did not update the analysis of intended effects. Data sources We searched Cochrane Central Register of Controlled Trials (CENTRAL), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, Epistemonikos, Medical Literature Analysis and Retrieval System Online (MEDLINE), Education Resources Information Center (ERIC) and Web of Science up to March 2025. In addition to studies from the original review and updated search, we included any additional studies included in a similar, even earlier review. Our unit of analysis was study report (eg, journal article). Eligibility criteria We included all studies from the original review. We applied the same inclusion criteria to the results of the updated search: the study included a comparison, the population was laypeople and the intervention was intended to improve understanding of ≥1 key concept for informed health choices. Data extraction and synthesis We extracted data about study design (randomised trial or other), participants (children, adolescents or adults), study setting (countries), main intervention (resources delivered to participants) and comparator (usual/no intervention or other). For the analysis, we extracted verbatim text describing any assessment of a potential adverse effect of the intervention. We conducted a narrative synthesis of the extracted data. Results We included 35 reports of quantitative studies (including multi-method and mixed-methods studies). Most often, the study was a randomised trial, the setting was a high-income country, the population included adults (including university students) and the intervention was school-based (including university). In one of the 35 reports, authors described assessing a potential adverse effect. Conclusion To our knowledge, this is the first systematic review assessing the extent to which researchers have assessed adverse effects of any category of educational interventions. Our review shows that researchers generally have not assessed potential adverse effects of interventions to improve critical thinking about health choices. Researchers should pay more attention to such effects, while policymakers and educators making decisions about implementing relevant interventions should consider the lack of evidence. The findings of this study suggest a need for research that facilitates assessing potential adverse effects of interventions to improve critical thinking about health choices.

26 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
GCGeovanna Cárdenas
Geovanna Cárdenas
FNFrancisco Novillo
Francisco Novillo
SLShuheng Lai
Shuheng Lai
HFHéctor Fuenzalida
Héctor Fuenzalida
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
GRGabriel Rada
Gabriel Rada
Objective The objective of this systematic review is to assess the impact of oxymetazoline in patients with moderate to severe rosacea. Data Sources We will conduct a comprehensive search in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Lilacs, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH) and grey literature, to identify all relevant randomized controlled trials regardless of language or publication status (published, unpublished, in press and in progress). Eligibility criteria for selecting studies and methods We will include randomized trials evaluating the effect of oxymetazoline in patients with moderate to severe rosacea. Two reviewers will independently screen each study for eligibility, data extraction, and assess the risk of bias. We will pool the results using meta-analysis and will apply the GRADE [1] system to assess the certainty of the evidence for each outcome. Ethics and Dissemination No ethics approval is considered necessary. The results of this review will be widely disseminated via peer-reviewed publications, social networks and traditional media. Protocol and Registration This protocol was adapted to the specificities of the question assessed in this review and registered to PROSPERO with the ID CRD42020150262.

12 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SLShuheng Lai
Shuheng Lai
FNFrancisco Novillo
Francisco Novillo
GCGeovanna Cárdenas
Geovanna Cárdenas
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
GRGabriel Rada
Gabriel Rada
Objective The objective of this systematic review is to assess the effectiveness and safety of Hyaluronic Acid (HA) on tissue and bone regeneration after tooth extraction. Data Sources We will conduct a comprehensive search in Epistemonikos, PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), LILACS, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH) and grey literature, to identify all relevant randomized controlled trials regardless of language or publication status (published, unpublished, in press and in progress). Eligibility Criteria for Selecting Studies and Methods We will include randomized trials evaluating the effect of HA on tissue and bone regeneration after tooth extraction. Two reviewers will independently screen each study for eligibility, data extraction, and assess the risk of bias. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome. Ethics and Dissemination No ethics approval is considered necessary. The results of this review will be disseminated via peer-reviewed publications, social networks, and traditional media. PROSPERO Registration ID CRD42020150285

28 July 2023
Verified
Report
Closed access
JRJosé Ramos-Rojas
José Ramos-Rojas
FNFrancisco Novillo
Francisco Novillo
DNDaniel Nava
Daniel Nava
CACamila Avila
Camila Avila
AGAna María Rojas Gómez
Ana María Rojas Gómez
VVValentina Veloso
Valentina Veloso

26 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
FNFrancisco Novillo
Francisco Novillo
SLShuheng Lai
Shuheng Lai
GCGeovanna Cárdenas
Geovanna Cárdenas
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
GRGabriel Rada
Gabriel Rada
Objective The objective of this systematic review is to assess the impact of periodontal therapy on disease activity of patients with Rheumatoid Arthritis Data Sources We will conduct a comprehensive search in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Lilacs, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH) and grey literature, to identify all relevant randomized controlled trials regardless of language or publication status (published, unpublished, in press and in progress). Elegibility Criteria for Selecting Studies and Methods We will include randomised trials evaluating the effect of periodontal therapy on disease activity of rheumatoid arthritis. Two reviewers will independently screen each study for eligibility, data extraction, and assess the risk of bias. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome. Ethics and Dissemination No ethics approval is considered necessary. The results of this review will be disseminated via peer-reviewed publications, social networks and traditional media. PROSPERO Registration ID CRD42020150286.